<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="./10_1101_676155v1/results/search/disease/results.xml">
  <result pre=" Metagenomic Nanopore sequencing of" exact="influenza" post="virus direct from clinical respiratory samples | bioRxiv Abstract"/>
  <result pre="viral sequencing offers the potential of a diagnostic test for" exact="influenza" post="which also provides insights on transmission, evolution and drug"/>
  <result pre="Nanopore Technology to metagenomic sequencing of respiratory samples. We generated" exact="influenza" post="reads down to a limit of detection of 10"/>
  <result pre="strong relationship between the viral titre and the proportion of" exact="influenza" post="reads (p = 4.7×10 -5). Applying our methods to"/>
  <result pre="-5). Applying our methods to clinical throat swabs, we generated" exact="influenza" post="reads for 27/27 samples with high-to-mid viral titres (Cycle"/>
  <result pre="influenced by increased host and bacterial reads. However, at high" exact="influenza" post="titres, we were able to reconstruct &amp;gt;;99% complete sequence"/>
  <result pre="to be used in the diagnosis and genetic analysis of" exact="influenza" post="and other respiratory viruses. Introduction Influenza A is an"/>
  <result pre="list of ‘ten threats to global health’ [ 7]. Seasonal" exact="influenza" post="causes an estimated 650,000 deaths globally each year, and"/>
  <result pre="adults, infants and young children, pregnant women, those with underlying" exact="lung disease," post="and the immunocompromised [ 9]. The burden of disease"/>
  <result pre="Inhibitors (NAI) [ 9]. Currently, most clinical diagnostic tests for" exact="influenza" post="depend on detecting viral antigen, or PCR amplification of"/>
  <result pre="a non-quantitative (binary) diagnostic result, and the data generated for" exact="influenza" post="have limited capacity to inform insights into epidemiological linkage,"/>
  <result pre="application of Oxford Nanopore Technologies (ONT; https://nanoporetech.com/) to generate full-length" exact="influenza" post="sequences from clinical respiratory samples can address these challenges."/>
  <result pre="viruses [ 21, 23– 25]. To date, Nanopore sequencing of" exact="influenza" post="has been reported using high titre virus from an"/>
  <result pre="We therefore aimed to optimise a metagenomic protocol for detecting" exact="influenza" post="viruses directly from clinical samples using Nanopore sequencing. We"/>
  <result pre="(Illumina) sequencing, using clinical samples from hospital patients during an" exact="influenza" post="season, and samples from a laboratory controlled infection in"/>
  <result pre="viral reads derived from throat swabs We first sequenced five" exact="influenza" post="A positive and five influenza-negative throat swabs, each spiked"/>
  <result pre="extraction from the supernatant. We used a pooled set of" exact="influenza" post="A positive samples (concentration 10 6 genome copies/ml), to"/>
  <result pre="control spiked in at 10 4 genome copies/ml. Enrichment for" exact="influenza" post="and Hazara was similar for filtration vs centrifugation, based"/>
  <result pre="original protocol, using triplicate extractions from the pooled set of" exact="influenza" post="A positive samples, demonstrated no significant loss in performance"/>
  <result pre="retrieval of Hazara virus by Nanopore sequencing Starting with an" exact="influenza" post="A positive sample pool (10 6 genome copies/ml), we"/>
  <result pre="to show processing protocol through clinical and research pipelines for" exact="influenza" post="diagnosis.&amp;lt;;/span&amp;gt;; (A) Clinical sample collection (orange), clinical diagnostic testing"/>
  <result pre="influenza-positive samples into influenza-negative background, to generate varying titres of" exact="influenza" post="virus (from zero up to 10&amp;lt;;sup&amp;gt;;6&amp;lt;;/sup&amp;gt;; genome copies/ml), undertaken"/>
  <result pre="to show processing protocol through clinical and research pipelines for" exact="influenza" post="diagnosis. (A) Clinical sample collection (orange), clinical diagnostic testing"/>
  <result pre="influenza-positive samples into influenza-negative background, to generate varying titres of" exact="influenza" post="virus (from zero up to 10 6 genome copies/ml),"/>
  <result pre="influenza-negative throat swabs, and Nanopore sequence results following spiking with" exact="influenza" post="A.&amp;lt;;/span&amp;gt;; (A) Total concentration of cDNA produced per pooled"/>
  <result pre="material, represented by the black filled bars. Samples diluted to" exact="influenza" post="titres of 10&amp;lt;;sup&amp;gt;;4&amp;lt;;/sup&amp;gt;;, 10&amp;lt;;sup&amp;gt;;3&amp;lt;;/sup&amp;gt;; and 10&amp;lt;;sup&amp;gt;;2&amp;lt;;/sup&amp;gt;; contain more cDNA"/>
  <result pre="generated by Nanopore sequencing of samples with different titres of" exact="influenza" post="A, and a consistent titre of Hazara virus (10&amp;lt;;sup&amp;gt;;4&amp;lt;;/sup&amp;gt;;"/>
  <result pre="Graphs show reads per million of total reads mapping to" exact="influenza" post="A or Hazara virus genomes, across the three individual"/>
  <result pre="influenza-negative throat swabs, and Nanopore sequence results following spiking with" exact="influenza" post="A.&amp;lt;;/span&amp;gt;; (A) Total concentration of cDNA produced per pooled"/>
  <result pre="material, represented by the black filled bars. Samples diluted to" exact="influenza" post="titres of 10&amp;lt;;sup&amp;gt;;4&amp;lt;;/sup&amp;gt;;, 10&amp;lt;;sup&amp;gt;;3&amp;lt;;/sup&amp;gt;; and 10&amp;lt;;sup&amp;gt;;2&amp;lt;;/sup&amp;gt;; contain more cDNA"/>
  <result pre="generated by Nanopore sequencing of samples with different titres of" exact="influenza" post="A, and a consistent titre of Hazara virus (10&amp;lt;;sup&amp;gt;;4&amp;lt;;/sup&amp;gt;;"/>
  <result pre="Graphs show reads per million of total reads mapping to" exact="influenza" post="A or Hazara virus genomes, across the three individual"/>
  <result pre="influenza-negative throat swabs, and Nanopore sequence results following spiking with" exact="influenza" post="A. (A) Total concentration of cDNA produced per pooled"/>
  <result pre="material, represented by the black filled bars. Samples diluted to" exact="influenza" post="titres of 10 4, 10 3 and 10 2"/>
  <result pre="generated by Nanopore sequencing of samples with different titres of" exact="influenza" post="A, and a consistent titre of Hazara virus (10"/>
  <result pre="Graphs show reads per million of total reads mapping to" exact="influenza" post="A or Hazara virus genomes, across the three individual"/>
  <result pre="from all three dilution series by Nanopore sequencing, independently of" exact="influenza" post="virus titre in the sample ( Fig 2B). Sequencing"/>
  <result pre="non-viral RNA was introduced from this high-background pool. Limit of" exact="influenza" post="virus detection by Nanopore from pooled samples Nanopore sequencing"/>
  <result pre="samples Nanopore sequencing of the triplicate SISPA preparations of the" exact="influenza" post="A positive pool produced mean 5.3×10 4 ±3.6×10 4"/>
  <result pre="produced mean 5.3×10 4 ±3.6×10 4 RPM mapping to the" exact="influenza" post="A genome ( Fig 2B). Across the dilution series,"/>
  <result pre="( Fig 2B). Across the dilution series, the proportion of" exact="influenza" post="reads was strongly associated with influenza virus titre (p-value"/>
  <result pre="series, the proportion of influenza reads was strongly associated with" exact="influenza" post="virus titre (p-value = 4.7×10 -5), but was also"/>
  <result pre="the Hazara control. Sequencing the negative controls (pools with no" exact="influenza" post="virus spike) generated no reads mapping to influenza. At"/>
  <result pre="influenza virus spike) generated no reads mapping to influenza. At" exact="influenza" post="virus titres &amp;lt;;10 3 copies/ml, influenza reads were inconsistently"/>
  <result pre="mapping to influenza. At influenza virus titres &amp;lt;;10 3 copies/ml," exact="influenza" post="reads were inconsistently detected across the samples ( Fig"/>
  <result pre="suggesting the limit of detection is between 10 2-10 3" exact="influenza" post="copies/ml. Retrieval and reconstruction of complete influenza genomes from"/>
  <result pre="10 2-10 3 influenza copies/ml. Retrieval and reconstruction of complete" exact="influenza" post="genomes from pooled/spiked samples For the Hazara virus control"/>
  <result pre="the high-background pool 3 to 5.7% ( Fig 3A). At" exact="influenza" post="titres &amp;lt;;10 4 copies/ ml, coverage was highly variable"/>
  <result pre="triplicate (shown as 3 dilution pools). ;&amp;lt;;div xmlns=&quot;;http://www.w3.org/1999/xhtml&quot;;&amp;gt;;&amp;lt;;span class=&quot;;caption-title&quot;;&amp;gt;;Coverage of" exact="influenza" post="and Hazara genome segments achieved by Nanopore sequencing from"/>
  <result pre="pooled samples&amp;lt;;/span&amp;gt;; (A) Data from three dilution series of pooled" exact="influenza" post="positive samples, diluted with three separate negative sample pools"/>
  <result pre="three separate negative sample pools to generate different titres of" exact="influenza" post="virus. Each individual dilution was spiked with Hazara at"/>
  <result pre="at 1x depth is shown for each of the eight" exact="influenza" post="genome segments (encoding: PB2 - polymerase subunit, PB1 -"/>
  <result pre="three genome segments for simplicity. (B) Representative coverage plot of" exact="influenza" post="A genome segments from the dilution series 1 sample"/>
  <result pre="genome segments from the dilution series 1 sample at 10&amp;lt;;sup&amp;gt;;4&amp;lt;;/sup&amp;gt;;" exact="influenza" post="copies per ml.&amp;lt;;/div&amp;gt;;&amp;lt;;/div&amp;gt;;&quot; data-icon-position=&quot;&quot; data-hide-link-title=&quot;0&quot;&amp;gt; Download figure Open in"/>
  <result pre="Download figure Open in new tab ;&amp;lt;;div xmlns=&quot;;http://www.w3.org/1999/xhtml&quot;;&amp;gt;;&amp;lt;;span class=&quot;;caption-title&quot;;&amp;gt;;Coverage of" exact="influenza" post="and Hazara genome segments achieved by Nanopore sequencing from"/>
  <result pre="pooled samples&amp;lt;;/span&amp;gt;; (A) Data from three dilution series of pooled" exact="influenza" post="positive samples, diluted with three separate negative sample pools"/>
  <result pre="three separate negative sample pools to generate different titres of" exact="influenza" post="virus. Each individual dilution was spiked with Hazara at"/>
  <result pre="at 1x depth is shown for each of the eight" exact="influenza" post="genome segments (encoding: PB2 - polymerase subunit, PB1 -"/>
  <result pre="three genome segments for simplicity. (B) Representative coverage plot of" exact="influenza" post="A genome segments from the dilution series 1 sample"/>
  <result pre="genome segments from the dilution series 1 sample at 10&amp;lt;;sup&amp;gt;;4&amp;lt;;/sup&amp;gt;;" exact="influenza" post="copies per ml.&amp;lt;;/div&amp;gt;;&amp;lt;;/div&amp;gt;;&quot; data-icon-position=&quot;&quot; data-hide-link-title=&quot;0&quot;&amp;gt; Download figure Open in"/>
  <result pre="Download figure Open in new tab Figure 3. Coverage of" exact="influenza" post="and Hazara genome segments achieved by Nanopore sequencing from"/>
  <result pre="pooled samples (A) Data from three dilution series of pooled" exact="influenza" post="positive samples, diluted with three separate negative sample pools"/>
  <result pre="three separate negative sample pools to generate different titres of" exact="influenza" post="virus. Each individual dilution was spiked with Hazara at"/>
  <result pre="at 1x depth is shown for each of the eight" exact="influenza" post="genome segments (encoding: PB2 - polymerase subunit, PB1 -"/>
  <result pre="three genome segments for simplicity. (B) Representative coverage plot of" exact="influenza" post="A genome segments from the dilution series 1 sample"/>
  <result pre="segments from the dilution series 1 sample at 10 4" exact="influenza" post="copies per ml. Influenza detection from individual clinical samples"/>
  <result pre="from individual clinical samples Having demonstrated our ability to retrieve" exact="influenza" post="sequences from pooled influenza-positive material diluted with negative samples,"/>
  <result pre="6 (median 3.8×10 5) (Table S1). Reads mapping to either" exact="influenza" post="A or B genomes were present in all 27"/>
  <result pre="6 to 274,955 reads). At Ct &amp;gt;;30, 6/13 samples generated" exact="influenza" post="reads (range 6 to 92,057), (difference between sensitivity at"/>
  <result pre="p&amp;lt;;0.0001, Fig 4) The highest Ct value at which any" exact="influenza" post="reads were detected was Ct 36.8 (Sample 37; 17"/>
  <result pre="reads were detected was Ct 36.8 (Sample 37; 17 reads" exact="influenza" post="A). No reads classified as influenza were obtained from"/>
  <result pre="(Sample 37; 17 reads influenza A). No reads classified as" exact="influenza" post="were obtained from sequencing the ten GeneXpert-negative samples (Table"/>
  <result pre="between Ct value and both reads per sample classified as" exact="influenza" post="(R-squared =0.604) and number of influenza reads per million"/>
  <result pre="per sample classified as influenza (R-squared =0.604) and number of" exact="influenza" post="reads per million reads (R-squared =0.623) ( Fig 4)."/>
  <result pre="=0.623) ( Fig 4). ;&amp;lt;;div xmlns=&quot;;http://www.w3.org/1999/xhtml&quot;;&amp;gt;;&amp;lt;;span class=&quot;;caption-title&quot;;&amp;gt;;Total and proportion of" exact="influenza" post="reads derived by Nanopore sequencing of individual samples across"/>
  <result pre="laboratory. (A) Correlation between Ct value and total number of" exact="influenza" post="reads generated. R&amp;lt;;sup&amp;gt;;2&amp;lt;;/sup&amp;gt;;= 0.604, p-value = 2.47e-08. (B) Correlation"/>
  <result pre="= 2.47e-08. (B) Correlation between Ct value and number of" exact="influenza" post="reads per million reads. R&amp;lt;;sup&amp;gt;;2&amp;lt;;/sup&amp;gt;;= 0.623, p-value = 1.07e-08.&amp;lt;;/div&amp;gt;;&amp;lt;;/div&amp;gt;;&quot;"/>
  <result pre="Open in new tab Figure 4: Total and proportion of" exact="influenza" post="reads derived by Nanopore sequencing of individual samples across"/>
  <result pre="laboratory. (A) Correlation between Ct value and total number of" exact="influenza" post="reads generated. R 2= 0.604, p-value = 2.47e-08. (B)"/>
  <result pre="= 2.47e-08. (B) Correlation between Ct value and number of" exact="influenza" post="reads per million reads. R 2= 0.623, p-value ="/>
  <result pre="generated no detectable Hazara reads, two with high numbers of" exact="influenza" post="reads (Sample 6: Ct 18.4, 1.5×10 4 influenza A"/>
  <result pre="numbers of influenza reads (Sample 6: Ct 18.4, 1.5×10 4" exact="influenza" post="A reads and Sample 1: Ct 13.5, 1.5×10 5"/>
  <result pre="influenza A reads and Sample 1: Ct 13.5, 1.5×10 5" exact="influenza" post="B reads) acting to dilute the control signal. The"/>
  <result pre="the control signal. The other two samples contained no detectable" exact="influenza" post="reads (Sample 34: Ct 35.9, Sample 46, Flu negative)."/>
  <result pre="Illumina MiSeq. Proportions of reads generated that mapped to the" exact="influenza" post="genome were similar across the two sequencing technologies ("/>
  <result pre="related sequences, as expected within one location in a single" exact="influenza" post="season, and complete concordance between the sequences obtained by"/>
  <result pre="reads mapping to Human Coronavirus in addition to &amp;gt;;1.5×10 4" exact="influenza" post="A reads, suggesting co-infection. We also derived &amp;gt;;4.0×10 4"/>
  <result pre="the reproducibility of our methods across a time-course model of" exact="influenza" post="A infection (three ferrets pre-infection (day -3) and then"/>
  <result pre="days 1, 2, 3 and 5 following laboratory infection with" exact="influenza" post="A). The proportion of viral reads present at each"/>
  <result pre="from the same cDNA. ;&amp;lt;;span xmlns=&quot;;http://www.w3.org/1999/xhtml&quot;; class=&quot;;caption-title&quot;;&amp;gt;;Time course experiment showing" exact="influenza" post="A infection in three laboratory ferrets.&amp;lt;;/span&amp;gt;; Infection was introduced"/>
  <result pre="(B) proportion of total nanopore reads (linear scale) mapping to" exact="influenza" post="A from metagenomic sequencing of ferret nasal washes taken"/>
  <result pre="metagenomic sequencing of ferret nasal washes taken pre and post" exact="influenza" post="challenge.&amp;lt;;/div&amp;gt;;&quot; data-icon-position=&quot;&quot; data-hide-link-title=&quot;0&quot;&amp;gt; Download figure Open in new tab"/>
  <result pre="Open in new tab Figure 6: Time course experiment showing" exact="influenza" post="A infection in three laboratory ferrets. Infection was introduced"/>
  <result pre="(B) proportion of total nanopore reads (linear scale) mapping to" exact="influenza" post="A from metagenomic sequencing of ferret nasal washes taken"/>
  <result pre="metagenomic sequencing of ferret nasal washes taken pre and post" exact="influenza" post="challenge. DISCUSSION To our knowledge, this is the first"/>
  <result pre="applying metagenomic Nanopore sequencing directly to respiratory samples to detect" exact="influenza" post="virus and generate influenza sequences. The approach demonstrates excellent"/>
  <result pre="directly to respiratory samples to detect influenza virus and generate" exact="influenza" post="sequences. The approach demonstrates excellent specificity; sensitivity varies by"/>
  <result pre="demonstrating the ability of metagenomics to produce sufficient data for" exact="influenza" post="diagnostics and genome characterisation, whilst also detecting and sequencing"/>
  <result pre="resistance alleles. IDSA guidelines [ 9] recommend nasal/nasopharyngeal specimens for" exact="influenza" post="diagnosis, but throat swabs are easier to collect in"/>
  <result pre="Nanopore reads confirms semi-quantitative output. Using samples from the ferret" exact="influenza" post="model, collected under standardized laboratory conditions, demonstrated excellent reproducibility"/>
  <result pre="clinical diagnostics to further assess sensitivity and specificity, and using" exact="influenza" post="sequence data to investigate transmission events. Identifying instances of"/>
  <result pre="the method is robust for the identification of commonly circulating" exact="influenza" post="strains in human populations, but further investigation is required"/>
  <result pre="animal) strains. In summary, our methods show promise for generating" exact="influenza" post="virus sequences directly from respiratory samples. The ‘pathogen agnostic’"/>
  <result pre="tested by a PCR-based test using GeneXpert (Cepheid) to detect" exact="influenza" post="A and B, and respiratory syncytial virus (RSV). Samples"/>
  <result pre="pooled 19 throat swab samples that had tested positive for" exact="influenza" post="A in the clinical diagnostic laboratory to provide a"/>
  <result pre="pools of throat swab samples that had tested negative for" exact="influenza" post="(consisting of 24, 38 and 38 individual samples respectively)"/>
  <result pre="swabs and 5 nasal swabs) that had tested positive for" exact="influenza" post="A or B, selected to represent the widest range"/>
  <result pre="samples: we selected 10 individual throat swab samples that were" exact="influenza" post="negative. Quantification of viral RNA in samples We quantified"/>
  <result pre="We quantified viral titres in Hazara virus stocks and pooled" exact="influenza" post="A positive throat swabs by qRT-PCR using previously described"/>
  <result pre="flu sequence database that included &amp;gt;;2,000 H1N1 and H3N2 seasonal" exact="influenza" post="sequences between 2018 and 2019, and downloaded from the"/>
  <result pre="samtools v1.5 and Pysam ( https://github.com/pysam-developers/pysam). The subtype of the" exact="influenza" post="A virus derived from each clinical sample was determined"/>
  <result pre="time course, from three days prior to first exposure with" exact="influenza" post="H1N1pdm09 and at days 1, 2, 3 and 5"/>
  <result pre=", Smith GJD . The ecology and adaptive evolution of" exact="influenza" post="A interspecies transmission. Influenza Other Respi Viruses. 2017; 11:"/>
  <result pre="11: 74– 84. OpenUrl 3. ↵ Humphreys M . The" exact="influenza" post="of 1918: Evolutionary perspectives in a historical context. Evol"/>
  <result pre="al. Origins and evolutionary genomics of the 2009 swine-origin H1N1" exact="influenza" post="A epidemic. Nature. 2009; 459: 1122– 1125. OpenUrl CrossRef"/>
  <result pre="X , Shen X , et al. Evolutionary dynamics of" exact="avian influenza" post="A H7N9 virus across five waves in mainland China,"/>
  <result pre=", Shen X , et al. Evolutionary dynamics of avian" exact="influenza" post="A H7N9 virus across five waves in mainland China,"/>
  <result pre=", et al. Molecular characterization of a nosocomial outbreak of" exact="influenza" post="B virus in an acute care hospital setting. J"/>
  <result pre="PCR-based point-of-care method facilitates rapid, efficient, and sensitive diagnosis of" exact="influenza" post="virus infection. Clin Microbiol Infect. 2018; doi: 10.1016/j.cmi.2018.12.017 OpenUrl"/>
  <result pre="J-M , He P-Y , et al. Dynamic quantification of" exact="avian influenza" post="H7N9(A) virus in a human infection during clinical treatment"/>
  <result pre=", He P-Y , et al. Dynamic quantification of avian" exact="influenza" post="H7N9(A) virus in a human infection during clinical treatment"/>
  <result pre="Nanopore and Illumina sequencing for recovering whole genome sequences of" exact="chikungunya" post="and dengue viruses directly from clinical samples. Euro Surveill."/>
  <result pre="al. Illumina and Nanopore methods for whole genome sequencing of" exact="hepatitis" post="B virus (HBV) [Internet]. bioRxiv. 2018. p. 470633. doi:"/>
  <result pre="Schönberger K , Sing A . Whole genome sequencing identifies" exact="influenza" post="A H3N2 transmission and offers superior resolution to classical"/>
  <result pre="Holmes EC . The genomic and epidemiological dynamics of human" exact="influenza" post="A virus. Nature. 2008; 453: 615– 619. OpenUrl CrossRef"/>
  <result pre="al. A naturally protective epitope of limited variability as an" exact="influenza" post="vaccine target. Nat Commun. 2018; 9: 3859. OpenUrl 34."/>
  <result pre="Ryan KA , Bean TJ , et al. Low dose" exact="influenza" post="virus challenge in the ferret leads to increased virus"/>
  <result pre="et al. Influenza research database: an integrated bioinformatics resource for" exact="influenza" post="research and surveillance. Influenza Other Respi Viruses. 2012; 6:"/>
 </snippets>
</snippetsTree>
